Listar Dpto. Ciencias de la Salud - Osasun Zientziak Saila por tema "KRASG12C inhibitors"
Mostrando ítems 1-1 de 1
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Drug combinations are key to circumvent resistance mechanisms compromising response to single anti-cancer targeted therapies. The implementation of combinatorial approaches involving MEK1/2 or KRASG12C inhibitors in the ...